Physician-Patient Dialogue and Clinical Evaluation of Erectile Dysfunction

Chun, Judy; Carson, Cully C.

doi:10.1016/s0094-0143(05)70135-x

Cited by 51 publications

(35 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Physicians need to be comfortable in speaking with their patients about ED and counseling them about the importance of ED in their lives. 28 Currently, more than 80% of men will respond to oral medications such as sildenafil. In those patients in whom responses are inadequate, second-line, third-line and combination therapy may help.…”

Section: Resultsmentioning

confidence: 99%

Erectile dysfunction in the 21st century: whom we can treat, whom we cannot treat and patient education

Carson

2002

Int J Impot Res

View full text Add to dashboard Cite

Erectile dysfunction affects 31 -52% of American men. Although considerable advances have been made in the diagnosis and treatment of erectile dysfunction in the past decade, more than 80% of men with erectile dysfunction are not treated because they do not seek medical attention or their physicians do not initiate a dialogue about sexual problems during their visits. This despite patients' desires to confront sexual problems and receive treatment. Most subgroups of men can now be effectively treated for sexual dysfunction. Although men with severe cardiac disease may require stabilization of their cardiac condition before treatment, most can successfully return to an active sex life. Some men, however, do not respond to the use of oral agents. These men can be treated with second-and third-line treatment modalities or with the newer concept of combinedmodality treatment. Despite excellent treatment alternatives, many men have low libido or hypoactive sexual desire disorder. In the ultimate resolution of a patient's sexual dysfunction, physicians must open a free and sympathetic dialogue and offer a full spectrum of treatment modalities tailored to the individual patient and partner. If initial treatment modalities fail, more invasive alternatives or combination therapy should be offered to cure the patient's erectile dysfunction.

show abstract

Section: Resultsmentioning

confidence: 99%

Erectile dysfunction in the 21st century: whom we can treat, whom we cannot treat and patient education

Carson

2002

Int J Impot Res

View full text Add to dashboard Cite

show abstract

“…28 Partners also have significant impact on treatment success and/or treatment discontinuation. 29,30 Unresolved partner issues may cause many patients to abandon their ED treatment despite the effectiveness of the drug. 31 Fortunately, many partners are skillful at facilitating a return to successful sexual activity.…”

Section: Introductionmentioning

confidence: 99%

Phosphodiesterase type 5 inhibitors’ extended duration of response as a variable in the treatment of erectile dysfunction

2006

View full text Add to dashboard Cite

“…9 Among these methods urologists can choose two pathways: either patients goal-directed approach or the so-called full evaluation. It is generally accepted that for every patient first level of investigations, medical and psychosexual history, physical examination and appropriate laboratory tests should be carried out.…”

Section: Discussionmentioning

confidence: 99%

Effect of aging on quality of nocturnal erections: evaluation with NPTR testing

et al. 2004

View full text Add to dashboard Cite

Nocturnal penile tumescence and rigidity testing (NPTR) has traditionally been performed to distinguish psychogenic from organic impotence. However, considerable lack of uniformly accepted normative data for NPTR readings makes the reproducibility of the method questionable. In this study, we try to evaluate the impact of aging as independent criteria for quality of erectile episodes. A total of 455 patients (ages 20-71 y) whose initial complaints were erectile dysfunction underwent two nights NPTR measurement with Rigiscan device. After analyzing the data, 353 men out of 455 were regarded as having normal NPTR recordings. The number of normal erectile episodes (erectile episode of penile tip rigidity greater than 60% more than 10 min duration), RAU Tip, RAU Base, TAU Tip, TAU Base, Average event rigidity of Tip (%), Average event rigidity of Base (%) and Duration of erectile episodes Z60% minute were re-evaluated with regard to five age groups (group I: o30 y; group II: 30-39 y; group III: 40-49 y; group IV: 50-59 y; group V: Z60 y). The mean values of erectile episodes in the age groups were as follows: group I, 2.46; group II, 2.28; group III, 2.40; group IV, 1.58; group V, 1.27. When we analyzed the groups between themselves, we observed statistically significant difference after the age of 50 y. The mean erectile episodes in patients younger than 50 y were 2.37 (s.d.: 1.50), whereas 1.49 (s.d.: 1.15) in patients older than 50 y (Po0.001). We also observed statistically significant difference at all of the above-mentioned NPTR parameters with regard to age. The results of our study showed that aging negatively influence quality of nocturnal erections especially after 50 y and we suggest that age needs to be taken into account in the diagnostic interpretation of NPTR testing.

show abstract

Physician-Patient Dialogue and Clinical Evaluation of Erectile Dysfunction

Cited by 51 publications

References 20 publications

Erectile dysfunction in the 21st century: whom we can treat, whom we cannot treat and patient education

Erectile dysfunction in the 21st century: whom we can treat, whom we cannot treat and patient education

Phosphodiesterase type 5 inhibitors’ extended duration of response as a variable in the treatment of erectile dysfunction

Effect of aging on quality of nocturnal erections: evaluation with NPTR testing

Contact Info

Product

Resources

About